Samyang to transfer Nicostop to Handok from March.

Published: 2007-03-06 06:56:00

Updated: 2007-03-06 06:56:00

Nicostop, a quit-smoking remedy, manufactured by Samyang, may be transferred to Handok for its distribution in Korea starting from coming March according to the report by Handok on Feb. 28.

Nicostop was developed by Samyang research laboratory as an alternative remedy of quitting smoking in he...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK